Tue, January 8, 2019
Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $125 on, Dec 19th, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-125-on-dec-19th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $185 to $125 on, Dec 19th, 2018.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Michael Schmidt of "Leerink Swann" Initiated at Buy and Held Target at $145 on, Wednesday, November 28th, 2018

Publication Contributing Sources